Michael J. Thomas

developer and medical device manufacturer in the respiratory disease market. He raised $25MM for iSonea and increased the company’s market capitalization from $4MM to $250MM during his tenure. He is a member of the Board of Directors for Circadiance LLC, a specialty CPAP mask manufacturer. He is also the President and CEO of Appian Partners, a medical devices and healthcare services consulting firm. Earlier in his career, Thomas was President and CEO of Sleep Solutions, a VC-­‐backed medical device manufacturer. He raised over $50 million in VC funding for that company and launch a new industry in the $5B Sleep Medicine market. He increased the company’s valuation from $1MM to over $70MM and ramped the company’s revenue from $0 to over $20MM during his tenure. Thomas successfully lobbied the largest Managed Care Organizations (MCOs) and the Centers for Medicare and Medicaid Services (CMS) to alter their medical policy and approve reimbursement for in-home sleep apnea diagnostic services. Prior to joining Sleep Solutions, Thomas was EVP of Sales and Marketing for National Sleep Technologies (NST), where he led acquisitions of more than 80 sleep labs, making NST the largest sleep testing company in the US, generating over $20MM in annual revenue. NST was later sold to GE Medical. Earlier in his career, Thomas was Vice President of Sales at Patient InfoSystems (NASDAQ: PATI) and instrumental in taking that company public. He and his team delivered an 80 X return to initial company shareholders at the IPO of PATI. He began his career in sales and marketing at Merck and GlaxoWellcome. Thomas graduated from Cornell University with a degree in Microbiology.